Response to Mörseburg et al

Affiliations

¹ Department of Physiology and Pharmacology, Biomedicum, Karolinska Institutet, 171 77 Stockholm, Sweden.
² Institute of Sport Science and Innovations, Lithuanian Sports University, 44221 Kaunas, Lithuania.
³ Murdoch Children's Research Institute, The Royal Children's Hospital Melbourne, Melbourne, VIC 3052, Australia; Department of Paediatrics, Melbourne Medical School, University of Melbourne, Melbourne, VIC 3010, Australia.
⁴ Department of Physiology and Pharmacology, Biomedicum, Karolinska Institutet, 171 77 Stockholm, Sweden; Heart, Vascular and Neurology Theme, Cardiology Unit, Karolinska University Hospital, 171 76 Stockholm, Sweden.
⁵ Institute of Sport Science and Innovations, Lithuanian Sports University, 44221 Kaunas, Lithuania. Electronic address: marius.brazaitis@lsu.lt.
⁶ Department of Physiology and Pharmacology, Biomedicum, Karolinska Institutet, 171 77 Stockholm, Sweden; Institute of Sport Science and Innovations, Lithuanian Sports University, 44221 Kaunas, Lithuania. Electronic address: hakan.westerblad@ki.se.

Comment

Victoria L Wyckelsma et al. Am J Hum Genet. 2022.

. 2022 May 5;109(5):973.

doi: 10.1016/j.ajhg.2022.03.017.

¹ Department of Physiology and Pharmacology, Biomedicum, Karolinska Institutet, 171 77 Stockholm, Sweden.
² Institute of Sport Science and Innovations, Lithuanian Sports University, 44221 Kaunas, Lithuania.
³ Murdoch Children's Research Institute, The Royal Children's Hospital Melbourne, Melbourne, VIC 3052, Australia; Department of Paediatrics, Melbourne Medical School, University of Melbourne, Melbourne, VIC 3010, Australia.
⁴ Department of Physiology and Pharmacology, Biomedicum, Karolinska Institutet, 171 77 Stockholm, Sweden; Heart, Vascular and Neurology Theme, Cardiology Unit, Karolinska University Hospital, 171 76 Stockholm, Sweden.
⁵ Institute of Sport Science and Innovations, Lithuanian Sports University, 44221 Kaunas, Lithuania. Electronic address: marius.brazaitis@lsu.lt.
⁶ Department of Physiology and Pharmacology, Biomedicum, Karolinska Institutet, 171 77 Stockholm, Sweden; Institute of Sport Science and Innovations, Lithuanian Sports University, 44221 Kaunas, Lithuania. Electronic address: hakan.westerblad@ki.se.

No abstract available

Comment on

Response to Wyckelsma et al.: Loss of α-actinin-3 during human evolution provides superior cold resilience and muscle heat generation.
Mörseburg A, Pagani L, Malyarchuk B, Derenko M, Kivisild T. Mörseburg A, et al. Am J Hum Genet. 2022 May 5;109(5):967-972. doi: 10.1016/j.ajhg.2022.03.014. Am J Hum Genet. 2022. PMID: 35523147 Free PMC article.

1. Mörseburg A., Pagani L., Malyarchuk B., Derenko M., Kivisild T. Response to Wyckelsma et al.: Loss of a-actinin-3 during human evolution provides superior cold resilience and muscle heat generation. Am. J. Hum. Genet. 2022;108 doi: 10.1016/j.ajhg.2022.03.014. - DOI - PMC - PubMed
1. Wyckelsma V.L., Venckunas T., Houweling P.J., Schlittler M., Lauschke V.M., Tiong C.F., Wood H.D., Ivarsson N., Paulauskas H., Eimantas N., et al. Loss of alpha-actinin-3 during human evolution provides superior cold resilience and muscle heat generation. Am. J. Hum. Genet. 2021;108:446–457. doi: 10.1016/j.ajhg.2021.01.013. - DOI - PMC - PubMed
1. MacArthur D.G., Seto J.T., Raftery J.M., Quinlan K.G., Huttley G.A., Hook J.W., Lemckert F.A., Kee A.J., Edwards M.R., Berman Y., et al. Loss of ACTN3 gene function alters mouse muscle metabolism and shows evidence of positive selection in humans. Nat. Genet. 2007;39:1261–1265. doi: 10.1038/ng2122. - DOI - PubMed
1. Friedlander S.M., Herrmann A.L., Lowry D.P., Mepham E.R., Lek M., North K.N., Organ C.L. ACTN3 allele frequency in humans covaries with global latitudinal gradient. PLoS One. 2013;8 doi: 10.1371/journal.pone.0052282. - DOI - PMC - PubMed
1. Amorim C.E.G., Acuna-Alonzo V., Salzano F.M., Bortolini M.C., Hunemeier T. Differing evolutionary histories of the ACTN3∗R577X polymorphism among the major human geographic groups. PLoS One. 2015;10 doi: 10.1371/journal.pone.0115449. - DOI - PMC - PubMed